{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:34:35Z","timestamp":1791297275565,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T00:00:00Z","timestamp":1395100800000},"content-version":"vor","delay-in-days":382,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancercell.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ccr.2013.01.026","type":"journal-article","created":{"date-parts":[[2013,3,18]],"date-time":"2013-03-18T12:06:09Z","timestamp":1363608369000},"page":"347-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"title":["Ablation of Fbxw7 Eliminates Leukemia-Initiating Cells by Preventing Quiescence"],"prefix":"10.1016","volume":"23","author":[{"given":"Shoichiro","family":"Takeishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Onoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Naka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi\u00a0I.","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2013.01.026_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2013.01.026_bib2","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.026_bib3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccr.2013.01.026_bib4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/300765a0","article-title":"A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia","volume":"300","author":"de Klein","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.026_bib5","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.026_bib6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2013.01.026_bib7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature07815","article-title":"IFNalpha activates dormant haematopoietic stem cells in\u00a0vivo","volume":"458","author":"Essers","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.026_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bmcl.2008.12.025","article-title":"Small-molecule perturbation of competing interactions between c-Myc and Max","volume":"19","author":"Follis","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ccr.2013.01.026_bib9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ccr.2013.01.026_bib10","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nn.2644","article-title":"Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun","volume":"13","author":"Hoeck","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ccr.2013.01.026_bib11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1158\/0008-5472.CAN-06-2014","article-title":"Growth factor stimulation reduces residual quiescent chronic myelogenous leukemia progenitors remaining after imatinib treatment","volume":"67","author":"Holtz","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2013.01.026_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrc1592","article-title":"Leukaemia stem cells and the evolution of cancer-stem-cell research","volume":"5","author":"Huntly","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2013.01.026_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature09732","article-title":"SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction","volume":"471","author":"Inuzuka","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.026_bib14","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","article-title":"PML targeting eradicates quiescent leukaemia-initiating cells","volume":"453","author":"Ito","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.026_bib15","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood-2006-11-057521","article-title":"Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells","volume":"109","author":"J\u00f8rgensen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.026_bib16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2013.01.026_bib17","first-page":"979","article-title":"Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells","volume":"22","author":"Kodama","year":"1994","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ccr.2013.01.026_bib18","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1126\/science.285.5434.1733","article-title":"A chemical inhibitor of p53 that\u00a0protects mice from the side effects of cancer therapy","volume":"285","author":"Komarov","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ccr.2013.01.026_bib19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.026_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ceb.2009.09.006","article-title":"Myc\u2019s other life: stem cells and beyond","volume":"21","author":"Laurenti","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ccr.2013.01.026_bib21","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccr.2013.01.026_bib22","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.1162981","article-title":"FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression","volume":"321","author":"Mao","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ccr.2013.01.026_bib23","doi-asserted-by":"crossref","first-page":"13754","DOI":"10.1074\/jbc.M110.194936","article-title":"Fbxw7-dependent degradation of Notch is required for control of \u201cstemness\u201d and neuronal-glial differentiation in neural stem cells","volume":"286","author":"Matsumoto","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccr.2013.01.026_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.stem.2011.06.014","article-title":"p57 is required for quiescence and maintenance of adult hematopoietic stem cells","volume":"9","author":"Matsumoto","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ccr.2013.01.026_bib25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gad.1621808","article-title":"Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL","volume":"22","author":"Matsuoka","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2013.01.026_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-\u03b2-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.026_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrc1881","article-title":"Ubiquitin ligases: cell-cycle control and cancer","volume":"6","author":"Nakayama","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2013.01.026_bib28","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1084\/jem.20062299","article-title":"Conditional inactivation of Fbxw7 impairs cell-cycle exit during T\u00a0cell differentiation and results in lymphomatogenesis","volume":"204","author":"Onoyama","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccr.2013.01.026_bib29","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","article-title":"Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow","volume":"92","author":"Pear","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.026_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ni.1839","article-title":"Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex","volume":"11","author":"Reavie","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccr.2013.01.026_bib31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.026_bib32","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.20080277","article-title":"Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7","volume":"205","author":"Thompson","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccr.2013.01.026_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09779","article-title":"Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7","volume":"471","author":"Wertz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.026_bib34","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2011.09.053","article-title":"Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche","volume":"147","author":"Yamazaki","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2013.01.026_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature04703","article-title":"Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells","volume":"441","author":"Yilmaz","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.026_bib36","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V92.10.3829","article-title":"Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia","volume":"92","author":"Zhang","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.026_bib37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of \u03b2-catenin impairs the renewal of normal and CML stem cells in\u00a0vivo","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610813000457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610813000457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T21:25:07Z","timestamp":1595539507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610813000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1535610813000457"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2013.01.026","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717991315.793494435","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717991315.793473448","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ablation of Fbxw7 Eliminates Leukemia-Initiating Cells by Preventing Quiescence","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2013.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2013.01.025","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}